Companies / BioMarin Pharmaceutical Inc / Activity
Activity — BioMarin Pharmaceutical Inc
17 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | New | Common stock | $76.98M | +1.4M | 1,362,752 0.70% of shares | high |
| Q1 2026 as of | Deerfield Management Company, L.P. 13F manager | New | Common stock | $48.10M | +852K | 851,556 0.44% of shares | medium |
| Q1 2021 as of | Employees Provident Fund Board 13F manager | New | Common stock | $29.04M | +385K | 384,634 0.20% of shares | medium |
| Q2 2026 as of | Monaco Asset Management SAM 13F manager | New | Common stock | $10.58M | +185K | 184,937 0.10% of shares | medium |
| Q1 2026 as of | Nordea Investment Management AB 13F manager | New | Common stock | $6.32M | +114K | 113,902 0.06% of shares | medium |
| Q2 2026 as of | Privium Fund Management B.V. 13F manager | New | Common stock | $4.29M | +75K | 75,000 0.04% of shares | low |
| Q1 2026 as of | Brighton Jones LLC 13F manager | New | Common stock | $1.57M | +28K | 27,779 0.01% of shares | low |
| Q1 2026 as of | &Partners 13F manager | New | Common stock | $533.5K | +9K | 8,619 <0.01% of shares | low |
| Q1 2026 as of | Knightsbridge Asset Management, LLC 13F manager | New | Common stock | $283.1K | +5K | 5,011 <0.01% of shares | low |
| Q2 2026 as of | Citizens Financial Group INC/RI 13F manager | New | Common stock | $245.0K | +4K | 4,281 <0.01% of shares | low |
| Q1 2026 as of | Sanders Morris Harris LLC 13F manager | New | Common stock | $226.0K | +4K | 4,000 <0.01% of shares | low |
| Q2 2026 as of | Salomon & Ludwin, LLC 13F manager | New | Common stock | $11.7K | +203 | 203 <0.01% of shares | low |
| Q2 2026 as of | CVA Family Office, LLC 13F manager | New | Common stock | $9.8K | +171 | 171 <0.01% of shares | low |
| Q2 2025 as of | Elevation Point Wealth Partners, LLC 13F manager | New | Common stock | $9.5K | +172 | 172 <0.01% of shares | low |
| Q2 2026 as of | Harbor Capital Advisors, Inc. 13F manager | New | Common stock | $912 | +16K | 15,944 <0.01% of shares | low |
| Q1 2026 as of | Natixis Advisors, LLC 13F manager | New | Common stock | $769 | +14K | 13,617 <0.01% of shares | low |
| Q1 2026 as of | Praxis Investment Management Inc 13F manager | New | Common stock | $317 | +6K | 5,611 <0.01% of shares | low |